| pubmed-article:9638789 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9638789 | lifeskim:mentions | umls-concept:C0242692 | lld:lifeskim |
| pubmed-article:9638789 | lifeskim:mentions | umls-concept:C0597304 | lld:lifeskim |
| pubmed-article:9638789 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:9638789 | pubmed:dateCreated | 1998-7-23 | lld:pubmed |
| pubmed-article:9638789 | pubmed:abstractText | The ubiquitin-proteasome proteolytic pathway has recently been reported to be of major importance in the breakdown of skeletal muscle proteins. The first step in this pathway is the covalent attachment of polyubiquitin chains to the targeted protein. Polyubiquitylated proteins are then recognized and degraded by the 26S proteasome complex. In this review, we critically analyse recent findings in the regulation of this pathway, both in animal models of muscle wasting and in some human diseases. The identification of regulatory steps of ubiquitin conjugation to protein substrates and/or of the proteolytic activities of the proteasome should lead to new concepts that can be used to manipulate muscle protein mass. Such concepts are essential for the development of anti-cachectic therapies for many clinical situations. | lld:pubmed |
| pubmed-article:9638789 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9638789 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9638789 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9638789 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9638789 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9638789 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9638789 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9638789 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9638789 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9638789 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9638789 | pubmed:issn | 0926-5287 | lld:pubmed |
| pubmed-article:9638789 | pubmed:author | pubmed-author:RéO NON | lld:pubmed |
| pubmed-article:9638789 | pubmed:author | pubmed-author:AttaixDD | lld:pubmed |
| pubmed-article:9638789 | pubmed:author | pubmed-author:SouweineBB | lld:pubmed |
| pubmed-article:9638789 | pubmed:author | pubmed-author:AurousseauEE | lld:pubmed |
| pubmed-article:9638789 | pubmed:author | pubmed-author:TaillandierDD | lld:pubmed |
| pubmed-article:9638789 | pubmed:author | pubmed-author:LarbaudDD | lld:pubmed |
| pubmed-article:9638789 | pubmed:author | pubmed-author:CombaretLL | lld:pubmed |
| pubmed-article:9638789 | pubmed:author | pubmed-author:RallièreCC | lld:pubmed |
| pubmed-article:9638789 | pubmed:author | pubmed-author:TilignacTT | lld:pubmed |
| pubmed-article:9638789 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9638789 | pubmed:volume | 38 | lld:pubmed |
| pubmed-article:9638789 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9638789 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9638789 | pubmed:pagination | 153-65 | lld:pubmed |
| pubmed-article:9638789 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9638789 | pubmed:meshHeading | pubmed-meshheading:9638789-... | lld:pubmed |
| pubmed-article:9638789 | pubmed:meshHeading | pubmed-meshheading:9638789-... | lld:pubmed |
| pubmed-article:9638789 | pubmed:meshHeading | pubmed-meshheading:9638789-... | lld:pubmed |
| pubmed-article:9638789 | pubmed:meshHeading | pubmed-meshheading:9638789-... | lld:pubmed |
| pubmed-article:9638789 | pubmed:meshHeading | pubmed-meshheading:9638789-... | lld:pubmed |
| pubmed-article:9638789 | pubmed:meshHeading | pubmed-meshheading:9638789-... | lld:pubmed |
| pubmed-article:9638789 | pubmed:meshHeading | pubmed-meshheading:9638789-... | lld:pubmed |
| pubmed-article:9638789 | pubmed:meshHeading | pubmed-meshheading:9638789-... | lld:pubmed |
| pubmed-article:9638789 | pubmed:meshHeading | pubmed-meshheading:9638789-... | lld:pubmed |
| pubmed-article:9638789 | pubmed:articleTitle | Ubiquitin-proteasome-dependent proteolysis in skeletal muscle. | lld:pubmed |
| pubmed-article:9638789 | pubmed:affiliation | Centre de recherche en nutrition humaine de Clermont-Ferrand, Ceyrat, France. attaix@clermont.inra.fr | lld:pubmed |
| pubmed-article:9638789 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9638789 | pubmed:publicationType | Review | lld:pubmed |
| pubmed-article:9638789 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9638789 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9638789 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9638789 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9638789 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9638789 | lld:pubmed |
